Obalon Therapeutics, Inc. (OBLN)

[conix]

OBLN INVESTMENT HIGHLIGHTS:

*Obesity is one of largest causes of chronic diseases globally - but preventable and reversible

*FDA-approved; Patented; Proprietary Technology

*53+ patents issued World-wide; 79 patents pending

*High levels of potential patient interest

*11 million people have expressed interest in paying for Obalon Balloon Treatment

*Over 160 million Adults are overweight and/or obese in the U.S.

*Average weight loss of over 21 pounds treated with Obalon Balloon System

Symbol: OBLN

TRADES:NASDAQ

Profile:




website: www.obalon.com